Stock CTMX CYTOMX THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions CytomX Therapeutics, Inc.

Equities

CTMX

US23284F1057

Real-time Estimate Cboe BZX
Other stock markets
 12:19:45 2024-05-10 pm EDT 		5-day change 1st Jan Change
1.885 USD -7.60% Intraday chart for CytomX Therapeutics, Inc. -57.34% +21.94%
May. 09 BMO Capital Adjusts Price Target on CytomX Therapeutics to $3.59 From $3.25, Maintains Market Perform Rating MT
May. 09 Wedbush Upgrades CytomX Therapeutics to Outperform From Neutral, Adjusts Price Target to $8 From $3 MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. CTMX Stock
  4. Revisions CytomX Therapeutics, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW